Employer Issues: Trade Secrets & Class Action Lawsuits [VIDEO]
Wednesday, October 30, 2013
Print Mail Download info_icon_img/>i

David Barmak, a trial lawyer and advisor to businesses at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. discusses two serious issues facing employers: class action suits and the loss of trade secrets.

©1994-2025 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. All Rights Reserved.

Current Public Notices

Current Legal Analysis

More from Mintz

Twenty States Sue the Trump Administration for HHS Program Eliminations and Staff Layoffs
by: Joanne S. Hawana
Colorado Supreme Court Allows Climate Tort Litigation to Proceed
by: Jacob H. Hupart
Appeals Court Rejects AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program
by: Mitchell J. Clough , Xavier G. Hardy
CMS’s 2026 Final Medicare Advantage Rule Focuses on Implementing the IRA and Deregulation
by: Tara E. Dwyer , Lauren M. Moldawer
Arkansas Law Takes Unprecedented Step to Prohibit PBM Ownership of Pharmacies
by: Theresa C. Carnegie , Hassan Shaikh
White House Budget Documents Provide Additional Insights into the Trump Administration’s Priorities for HHS
by: Lauren M. Moldawer , Joanne S. Hawana
Trump Administration Files Preemptive Lawsuits Against Hawaii and Michigan to Block Climate Change Litigation
by: Jacob H. Hupart
Trump Administration Issues Drug Pricing Executive Order
by: Theresa C. Carnegie , Xavier G. Hardy
Trump Issues Executive Order Targeting State Action on Climate Change
by: Jacob H. Hupart
Eighth Circuit Holds SEC Climate Rule Litigation in Abeyance
by: Jacob H. Hupart
Deregulatory Push by Trump Administration Picks Up Speed
by: Joanne S. Hawana , Lauren M. Moldawer
OIG Issues Another Favorable Advisory Opinion on Patient Recruitment Efforts by Community Health Centers
by: Rachel E. Yount
HHS Restructuring and Workforce Reductions – Key Implications for the Health Care Industry
by: Joanne S. Hawana , Jean D. Mancheno
A Texas Federal Court Sides with Laboratories, But There May Be Unintended Consequences for FDA
by: Benjamin M. Zegarelli , Joanne S. Hawana
Seller Considerations When Negotiating a Letter of Intent
by: Jeremy D. Glaser , Stephen M. Callegari

Upcoming Events